![](/img/cover-not-exists.png)
Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors
Christina M. Annunziata, Elise C. Kohn, Patricia LoRusso, Nicole D. Houston, Robert L. Coleman, Manuela Buzoianu, Gabriel Robbie, Robert LechleiderVolume:
31
Language:
english
DOI:
10.1007/s10637-012-9801-2
Date:
February, 2013
File:
PDF, 154 KB
english, 2013